Home Kit Includes:

– 1 month supply of Tirzepatide Injection
(Dosage varies from 2.5mg to 15mg and is dependent on the Month ordered)
– Syringes
– Alcohol Pads
– Physician Consultation [online]

Procedure:

Subqutaneous (Sub-q) Injection, self-administered in fatty abdominal area or thigh.
Video tutorial provided after purchase.

Purpose:

Tirzepatide has been shown to promote weight loss in people with type 2 diabetes. It works by reducing appetite and increasing feelings of fullness, which can lead to decreased food intake and subsequent weight reduction.

Dosage and Frequency:

– Once a week
Taken on the same day each week, any time of day, with or without food.
(Detailed dosing schedule will be provided with Homekit).

Diet and Exercise:

Healthy eating and activity are recommended.

Benefits:

– Weight Loss
– May improve Blood Pressure
– May improve cholesterol
– Improves Blood Sugar

Most Common Side Effect (Full list below):

Nausea (Recommendations to limit Nausea: Eat bland, low-fat foods, like crackers, toast and rice. Eat foods that contain water, like soup and gelatin. Avoid laying down after eating. Eat slowly. Go outdoors for fresh air.)

TeleHealth Consultation:

A physician may contact you within 24 hours of purchase if additional information is needed.

IMPORTANT!

THIS PRODUCT FOLLOWS A TITRATION SCHEDULE. ALL PATIENTS MUST START WITH ‘MONTH 1’ DOSE. AFTER MONTH 1, THE DOSAGE PER INJECTION INCREASES GRADUALLY IN MONTH 2, 3, AND 4. LASTLY THE MAINTENAINCE DOSE CAN BE ONGOING FOR UP TO 8 MONTHS DEPENDING ON YOUR GOALS

A MINIMUM BMI OF 27 OR GREATER IS REQUIRED TO ORDER THIS PRODUCT

Shipping:

This product can be shipped 2-Day or Overnight and does not need to be refrigerated during shipping. As a precaution, please refrigerate once received and opened.

What is Tirzepatide?

Tirzepatide is a medication that belongs to a class of drugs called glucagon-like peptide-1 receptor agonist (GLP-1 RA) and glucagon receptor antagonist (GRA) dual agonists. It is used for the treatment of type 2 diabetes mellitus.

Tirzepatide works by mimicking the action of a naturally occurring hormone called glucagon-like peptide-1 (GLP-1) and blocking the action of another hormone called glucagon. By doing so, it helps regulate blood sugar levels in individuals with type 2 diabetes.

Some key features and benefits of tirzepatide include:

1. Blood sugar control:

Tirzepatide helps lower blood sugar levels by stimulating the release of insulin, which helps move glucose into cells for energy, and by reducing the production of glucose in the liver.

2. Weight management:

Tirzepatide has been shown to promote weight loss in people with type 2 diabetes. It works by reducing appetite and increasing feelings of fullness, which can lead to decreased food intake and subsequent weight reduction.

3. Cardiovascular benefits:

Clinical trials have demonstrated that tirzepatide can reduce the risk of major adverse cardiovascular events, such as heart attacks and strokes, in people with type 2 diabetes who have established cardiovascular disease.

4. Once-weekly dosing:

Tirzepatide is administered once a week by subcutaneous injection, which offers convenience and may improve treatment adherence.

LEAVE A REVIEW

Tirzepatide is a promising medication with several potential benefits, particularly in the treatment of type 2 diabetes. Here are some of its key advantages:

1. Superior Glycemic Control: Tirzepatide has shown remarkable efficacy in reducing HbA1c levels in clinical trials. It works by targeting multiple pathways involved in blood sugar regulation, leading to better glycemic control. Patients often experience significant reductions in their blood sugar levels, which can reduce the risk of diabetes-related complications such as cardiovascular disease, kidney problems, and neuropathy.

2. Weight Loss: One of the unique advantages of Tirzepatide is its ability to promote weight loss. Unlike some other diabetes medications that may lead to weight gain, Tirzepatide is associated with significant weight loss as a side effect. This is particularly beneficial for individuals with type 2 diabetes who are also overweight or obese, as it can improve insulin sensitivity and contribute to overall better health.

3. Convenience: Tirzepatide comes in a once-weekly injection form, offering a convenient dosing regimen. This can be especially advantageous for individuals who may struggle with daily pill regimens or frequent injections. Improved medication adherence is crucial for effective diabetes management, and the simplicity of Tirzepatide can help patients stay on track with their treatment plan.

4. Potential Cardiovascular Benefits: Some preliminary research suggests that Tirzepatide may have positive effects on cardiovascular health. It has shown potential in reducing the risk of major adverse cardiovascular events in people with type 2 diabetes, which is an important consideration given the elevated risk of heart disease in this population.

5. Flexibility in Dosing: Tirzepatide offers flexibility in dosing, allowing healthcare providers to tailor treatment to individual patient needs. This customization can help optimize glycemic control while minimizing side effects.

In summary, Tirzepatide offers several potential benefits for individuals with type 2 diabetes, including improved glycemic control, weight loss, convenience in dosing, and potential cardiovascular advantages.

HOW DOES TIRZEPATIDE WORK?

It works through a unique mechanism involving the activation of two different types of receptors in the body: the glucagon-like peptide-1 (GLP-1) receptor and the glucose-dependent insulinotropic polypeptide (GIP) receptor. Here’s an overview of how it works:

1. GLP-1 Receptor Activation: GLP-1 is a hormone that plays a key role in glucose metabolism. When tirzepatide activates the GLP-1 receptor, several beneficial effects occur:

• Increased Insulin Secretion: In response to high blood glucose levels, the pancreas secretes more insulin. This is a primary mechanism by which tirzepatide helps lower blood sugar levels.

• Decreased Glucagon Secretion: Glucagon is a hormone that raises blood glucose levels. Tirzepatide reduces the secretion of glucagon, which helps in lowering blood sugar.

• Delay in Gastric Emptying: By slowing down the rate at which the stomach empties its contents into the small intestine, tirzepatide helps in controlling post-meal blood sugar spikes.

• Appetite Suppression: Activation of the GLP-1 receptor in the brain can lead to a reduction in appetite and food intake, aiding in weight loss.

2. GIP Receptor Activation: GIP is another hormone involved in glucose regulation. The activation of the GIP receptor by tirzepatide contributes to its effectiveness in a few ways:

• Enhanced Insulin Secretion: Similar to GLP-1, GIP promotes insulin secretion in response to high blood sugar. This effect is complementary to the action on the GLP-1 receptor.

• Improved Insulin Sensitivity: There’s evidence to suggest that GIP receptor activation can improve insulin sensitivity in peripheral tissues, such as muscle and fat, helping the body to use insulin more effectively.

3. Synergistic Effects: The dual action of tirzepatide, targeting both GLP-1 and GIP receptors, provides a synergistic effect in managing blood sugar levels. This dual mechanism is thought to be more effective than medications that target only one of these pathways.

By combining these mechanisms, tirzepatide effectively lowers blood glucose levels, aids in weight loss, and improves overall metabolic health in individuals with type 2 diabetes. Its ability to address several aspects of diabetes pathophysiology makes it a promising treatment option.

REFERENCES

The clinical trials for Tirzepatide have shown promising results in the treatment of type 2 diabetes. Here are the key findings from several significant studies:

1. “Tirzepatide Once Weekly for the Treatment of Obesity”: Participants in this study complete a 60-week Weight-Loss Period on Tirzepatide, followed by a 52-week Weight Maintenance Period, where they are assigned to either Tirzepatide 5 mg, the maximum tolerated dose of Tirzepatide, and saw successful results.

2. “Continued Treatment With Tirzepatide for Maintenance of Weight Reduction in Adults With Obesity”: You can find a detailed study on the maintenance of long-term weight loss with Tirzepatide, published in the Journal of the American Medical Association (JAMA).

3. “Blood pressure reduction with Tirzepatide in patients with type 2 diabetes”: A detailed study on the benefits of Tirzepatide in regards to blood pressure in patients with Type 2 Diabetes.

Overall, these studies collectively indicate that Tirzepatide could be a highly effective treatment option for type 2 diabetes, offering significant benefits in terms of blood glucose control and weight management.

LEAVE A REVIEW